Try a new search

Format these results:

Searched for:

in-biosketch:true

person:segevd01

Total Results:

1154


Replacing Unintentional Weight Loss with CT-Assessed Sarcopenia in the Physical Frailty Phenotype for Kidney Transplant Recipients [Meeting Abstract]

Chen, Xiaomeng; Shafaat, Omid; Liu, Yi; King, Elizabeth; Weiss, Clifford; Xue, Qian-Li; Walston, Jeremy; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700120
ISSN: 1600-6135
CID: 5133642

Antibody Response to a Third dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: mRNA and Viral Vector Boosters [Meeting Abstract]

Alejo, Jennifer; Bae, Sunjae; Mitchell, Jonathan; Chiang, Teresa; Boyarsky, Brian; Abedon, Aura; Chang, Amy; Avery, Robin; Tobian, Aaron; Massie, Allan; Levan, Macey; Warren, Daniel; Garonzik-Wang, Jacqueline; Segev, Dorry; Werbel, William
ISI:000739470700006
ISSN: 1600-6135
CID: 5133492

Development and Validation of a Light-Touch Frailty Phenotype for Clinical Use [Meeting Abstract]

Chen, Xiaomeng; Alasfar, Sami; Xue, Qian-Li; Norman, Silas; Walston, Jeremy; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700047
ISSN: 1600-6135
CID: 5133562

Effect of Post-Kidney Transplantation BMI Trajectories [Meeting Abstract]

Bendersky, Victoria; Liu, Yi; Chen, Xiaomeng; Harhay, Meera; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700036
ISSN: 1600-6135
CID: 5133552

Y A Machine Learning Model for Predicting Antibody Response to a 2-Dose SARS-CoV-2 mRNA Vaccine Series in Transplant Recipients [Meeting Abstract]

Alejo, Jennifer; Mitchell, Jonathan; Chiang, Teresa; Abedon, Aura; Werbel, William; Avery, Robin; Tobian, Aaron; Massie, Allan; Garonzik-Wang, Jacqueline; Segev, Dorry; Bae, Sunjae
ISI:000739470700024
ISSN: 1600-6135
CID: 5133542

Disparities in Access to Re-Kidney Transplantation after Graft Failure [Meeting Abstract]

Ahn, JiYoon; Sandal, Shaifali; Patole, Shalom; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700022
ISSN: 1600-6135
CID: 5133532

Post-Donation ESRD Risk Prediction Through Thirty Years [Meeting Abstract]

Massie, Allan; Snyder, Jon; Segev, Dorry
ISI:000739470700016
ISSN: 1600-6135
CID: 5133522

The Survival Benefit of Re-Kidney Transplantation in Older and Younger Patients with Graft Failure [Meeting Abstract]

Ahn, JiYoon; Sandal, Shaifali; Segev, Dorry; McAdams-DeMarco, Mara
ISI:000739470700012
ISSN: 1600-6135
CID: 5133512

Designing Continuous Distribution for Liver Allocation [Meeting Abstract]

Mankowski, Michal; Wood, Nicholas; Segev, Dorry; Gentry, Sommer
ISI:000739470700008
ISSN: 1600-6135
CID: 5133502

Temporal Trends in Utilization and Outcomes of DCD Livers in the United States

Ruck, Jessica M; Jackson, Kyle R; Motter, Jennifer D; Massie, Allan B; Philosophe, Benjamin; Cameron, Andrew M; Ottmann, Shane E; Wesson, Russell; Gurakar, Ahmet O; Segev, Dorry L; Garonzik-Wang, Jacqueline
BACKGROUND:Historically, donation after circulatory death (DCD) livers were frequently discarded due to higher mortality and graft loss after liver transplantation (LT). However, the demand for liver transplantation continues to outstrip the supply of "acceptable" organs. Additionally, changes in the donor pool, organ allocation, clinical management of donors and recipients, and improved clinical protocols might have altered post-DCD-LT outcomes. METHODS:We studied 5,975 recovered DCD livers using U.S. SRTR data from 2005-2017, with a comparison group of 78,235 adult DBD livers recovered during the same time period. We quantified temporal trends in discard using adjusted multilevel logistic regression and temporal trends in post-LT mortality and graft loss for DCD LT recipients using adjusted Cox regression. RESULTS:DCD livers were more likely to be discarded than DBD livers across the entire study period, and the relative likelihood of discard increased over time (adjusted odds ratio [aOR] of discard DCD vs. DBD 3.854.455.14 2005-2007, 5.225.876.59 2015-2017) despite improving outcomes after DCD LT. Mortality risk for DCD LTs decreased in each time period (compared to 2005-2007, aHR 2008-2011 0.720.840.97, aHR 2012-2014 0.480.580.70, aHR 2015-2017 0.340.430.55), as did risk of graft loss (compared to 2005-2007, aHR 2008-2011 0.690.810.94, aHR 2012-2014 0.450.550.67, aHR 2015-2017 0.360.450.56). CONCLUSIONS:Despite dramatic improvements in outcomes of DCD LT recipients, DCD livers remain substantially more likely to be discarded than DBD livers, and this discrepancy has actually increased over time. DCD livers are underutilized and have the potential to expand the donor pool.
PMID: 34259435
ISSN: 1534-6080
CID: 5127412